Drug developmentToday, the Center for Translational Research (CTR) announced three major internal leadership changes within the corporate group. These changes mean that Anna Steneholm becomes the new CEO of Toxicology Knowledge Team Sweden AB (TKT). Current CEO Suzanne Iverson Hemberg will become the new CEO at sister company CTC Clinical Trial Consultants (CTC). CTC’s current CEO,
Category Archives: TKT News
The first episode of the podcast Idé till patient (Idea to patient) will be released on April 12. The podcast series is a co-production between the companies within the CTR-group and SwedenBIO. The series comprises six episodes where invited guests from the pharma industry will be discussing the pitfalls and highlights in early drug development. Episodes 2-4
Yesterday, on Mars 1, Suzanne Iverson Hemberg joined Toxicology Knowledge Team Sweden (TKT) as the new CEO. Suzanne brings over 20 years of leadership as a Senior Scientist and Director of laboratory- and knowledge-based organisations in both public and private sectors in Canada and Sweden. With scientific expertise in drug metabolism and adverse drug reactions
Today, on February 15, Hanna Anderson joins Toxicology Knowledge Team Sweden (TKT) as a Junior Toxicology Consultant. Hanna Andersson recently graduated from the Master of Science Programme in Pharmacy from Uppsala University. Throughout the program, she always had an interest in drug safety, which led her to the field of toxicology and the opportunity to
As of March 1, 2022, Suzanne Iverson Hemberg will succeed Elinor Hahne and be appointed the new CEO for Toxicology Knowledge Team AB (TKT) in Sweden. Suzanne brings over 20 years of strong leadership as a Senior Scientist and Director of laboratory- and knowledge-based organisations in both public and private sectors in Canada and Sweden.
Press release April 6th, 2021 Center for Translational Research Sweden AB (CTR) acquires Toxicology Knowledge Team Sweden AB (TKT) further strengthening the CTR group with optimised toxicological support. From April 1, TKT is a fully owned subsidiary to the holding company CTR. The activities at TKT will continue without interruption and with the same staff,